Administration of vancomycin by continuous infusion is a reasonable dosing strategy, considering the drug's pharmacodynamic properties. Vancomycin exhibits time-dependent rather than ...

The rationale for measuring vancomycin concentrations has been to monitor its therapeutic efficacy and reduce its toxicity; however, the causal relationship between nephrotoxicity and ototoxicity and ...

Please provide your email address to receive an email when new articles are posted on . DALLAS — The current recommended dosing of intraperitoneal vancomycin for PD- associated peritonitis, as ...

Successful Migration to a Vancomycin AUC-dosing Protocol: Evaluation, Implementation and Outcomes in an Acute Care Hospital Setting Vancomycin, an antibiotic medication used to treat serious bacterial ...

SAN FRANCISCO, CA—Weight-based vancomycin dosing may provide a higher rate of adequate concentration for an entire surgical procedure—from the time of incision until complete wound closure—in patients ...

Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Not for prophylaxis of endophthalmitis. Renal insufficiency. Monitor hearing, blood, renal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Intraosseous delivery of vancomycin after tourniquet ...

JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leading provider of model informed precision dosing, today announced the availability of its new Vancomycin Hemodialysis (HD) model. Patients undergoing ...

VANCOMYCIN is a penicillinase-resistant antibiotic that may be used in the treatment of staphylococcal infections. Because it is known to be excreted chiefly through the kidneys in normal persons 1 ...

Amneal is voluntarily recalling four lots of Vancomycin Hydrochloride for Oral Solution, 250 mg/5 mL packaged in 80 mL, 150 mL or 300 mL pack sizes, to the consumer level. Some bottles may have been ...

LONDON, Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix ...